Surfshark Partners with dLocal to Power Its Global Expansion Across Africa, Asia, and Latin America

The partnership will enable the leading VPN provider to offer localized payments to customers in 13 new countries as part of the company’s overall growth strategy 14/12/2021 — MONTEVIDEO, Uruguay […]

Adagio Therapeutics Announces $336 Million Series C Financing to Support Rapid Advancement of Novel ADG20 #Antibody for the Treatment and Prevention of #COVID-19

Additional Capital to Fund Ongoing STAMP Pivotal Trial of ADG20 Designed to Support Emergency Use Authorization Submission Financing Follows First Quarter Appointment of Industry and Banking Veteran Jane Henderson as […]

Lady Gaga Partners with Clear Channel Outdoor in an Exclusive Global Unveiling of New ARTPOP Album Cover

Clear Channel Outdoor (NYSE:CCO) today announced that international recording artist Lady Gaga will reveal the cover artwork for her new album, ARTPOP, for the first time, in a piece by piece unveiling on Clear Channel Outdoor digital billboards and screens in major cities across the globe. The company is pushing the boundaries of its unparalleled international footprint and digital technologies with this first-ever out-of-home campaign that sequences a stepped reveal of advertiser creative in unison across the world. The campaign showcases the global scale, reach and impact of Clear Channel Outdoor’s digital inventory, which marries the oldest and most enduring advertising medium with the newest technologies to provide huge creative potential for brands to connect with people.

Otsuka Receives Opinion from CHMP on Delamanid

Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for delamanid for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB) in combination with an optimised background regimen (OBR) according to WHO guidelines in patients. The CHMP considered that the duration of treatment (two months) in the Phase IIb randomised controlled trial (Trial 204) was too short to establish the effectiveness of delamanid in treating tuberculosis when added to other anti-tuberculosis medicines.

Gillette Fields Team for the London 2012 Olympic Games

Gillette, a P&G brand, today introduced a team of 24 world-class athletes from 18 countries that will represent the world’s leading male grooming brand at the 2012 Olympic Games in London. The athletes include Roger Federer of Switzerland, Ryan Lochte of the United States, Lin Dan of China, Emmanuel Ginobili of Argentina and Sir Chris Hoy of Great Britain. Each of these athletes will participate in activities to help inspire and encourage future generations to achieve greatness through great starts in athletics – and in life.